Using our expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in cancer patients.
Our Science

Constellation is a pioneer in the discovery and development of novel therapeutics that target the writer, reader and eraser classes of epigenetic regulators and modulate gene expression in a more selective manner.
Our Programs